Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 7/20 | 0.38 |
| ▸ | BRD2 | P25440 | 7/20 | 0.38 |
| ▸ | BRD3 | Q15059 | 7/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 7/20 | 0.38 |
| ▸ | QPCT | Q16769 | 5/20 | 0.36 |
| ▸ | MDM4 | O15151 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22900428 | 0.86 | QPCT (0.40) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900538 | 0.85 | BRD4 (0.42) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900536 | 0.80 | BRD4 (0.40) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900351 | 0.79 | BRD4 (0.45) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900470 | 0.78 | QPCT (0.38) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900505 | 0.78 | QPCT (0.38) | QPCTMDM4MDM2 | |
| SCHEMBL22900272 | 0.74 | QPCT (0.38) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900269 | 0.74 | QPCT (0.38) | QPCTMDM4MDM2 | |
| SCHEMBL22900496 | 0.73 | QPCT (0.40) | BRD4BRD2BRD3CREBBPQPCT | |
| SCHEMBL22900277 | 0.72 | BRD4 (0.37) | BRD4BRD2BRD3CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021009068-A1 | N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME | SCENIC IMMUNOLOGY B.V. (NL) | 2021-01-21 | — | — | WO | disclosed |